Research output per year
Research output per year
Fingerprint
Dive into the research topics where Gaetano Corazzelli is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Network
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Response and toxicity to cytarabine therapy in leukemia and lymphoma: From dose puzzle to pharmacogenomic biomarkers
Di Francia, R., Crisci, S., De Monaco, A., Cafiero, C., Re, A., Iaccarino, G., De Filippi, R., Frigeri, F., Corazzelli, G., Micera, A. & Pinto, A., Mar 1 2021, In: Cancers. 13, 5, p. 1-39 39 p., 966.Research output: Contribution to journal › Review article › peer-review
Open Access -
Circulating dendritic cells deficiencies as a new biomarker in classical Hodgkin lymphoma
Galati, D., Zanotta, S., Corazzelli, G., Bruzzese, D., Capobianco, G., Morelli, E., Arcamone, M., De Filippi, R. & Pinto, A., Feb 2019, In: British Journal of Haematology. 184, 4, p. 594-604 11 p.Research output: Contribution to journal › Article › peer-review
-
Dendritic cells in hematological malignancies
Galati, D., Corazzelli, G., De Filippi, R. & Pinto, A., Dec 1 2016, In: Critical Reviews in Oncology/Hematology. 108, p. 86-96 11 p.Research output: Contribution to journal › Review article › peer-review
-
Feasibility and efficacy of dose-dense and dose-intense ABVD for high-risk patients with advanced Hodgkin lymphoma: Reply to D'Arco et al
Pinto, A. & Corazzelli, G., Nov 1 2015, In: British Journal of Haematology. 171, 4, p. 665-668 4 p.Research output: Contribution to journal › Article › peer-review
-
A phase II study of dose-dense and dose-intense ABVD (ABVDDD-DI) without consolidation radiotherapy in patients with advanced Hodgkin lymphoma
Russo, F., Corazzelli, G., Frigeri, F., Capobianco, G., Aloj, L., Volzone, F., De Chiara, A., Bonelli, A., Gatani, T., Marcacci, G., Donnarumma, D., Becchimanzi, C., de Lutio, E., Ionna, F., De Filippi, R., Lastoria, S. & Pinto, A., 2014, In: British Journal of Haematology. 166, 1, p. 118-129 12 p.Research output: Contribution to journal › Article › peer-review